GEO the bio marker established with the Sunrise patients along with other possible bio markers is a step in that direction. The case is building for a MOA. MSK and NCNN are part of this process with combo pre-clinical trails. It is clear there is some refining (trial design) required for maximum results on future trials. I visualize Bavi in the mix with several triple combination treatments for future trails.
Bavi will eventually be approved as a SOC in triple combination treatments in several cancers. IMO